226 related articles for article (PubMed ID: 27894300)
1. Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin.
Burgy O; Bellaye PS; Causse S; Beltramo G; Wettstein G; Boutanquoi PM; Goirand F; Garrido C; Bonniaud P
Respir Res; 2016 Nov; 17(1):162. PubMed ID: 27894300
[TBL] [Abstract][Full Text] [Related]
2. Antifibrotic role of αB-crystallin inhibition in pleural and subpleural fibrosis.
Bellaye PS; Burgy O; Colas J; Fabre A; Marchal-Somme J; Crestani B; Kolb M; Camus P; Garrido C; Bonniaud P
Am J Respir Cell Mol Biol; 2015 Feb; 52(2):244-52. PubMed ID: 25032514
[TBL] [Abstract][Full Text] [Related]
3. The small heat-shock protein αB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis.
Bellaye PS; Wettstein G; Burgy O; Besnard V; Joannes A; Colas J; Causse S; Marchal-Somme J; Fabre A; Crestani B; Kolb M; Gauldie J; Camus P; Garrido C; Bonniaud P
J Pathol; 2014 Mar; 232(4):458-72. PubMed ID: 24307592
[TBL] [Abstract][Full Text] [Related]
4. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.
Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J
J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking aggravates bleomycin-induced experimental pulmonary fibrosis.
Zhou LL; Wang M; Liu F; Lu YZ; Song LJ; Xiong L; Xiang F; He XL; Shuai SY; Xin JB; Ye H; Yu F; Ma WL
Toxicol Lett; 2019 Mar; 303():1-8. PubMed ID: 30572104
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between pleural mesothelial cell and lung fibroblast contributes to pulmonary fibrosis.
Liu F; Yu F; Lu YZ; Cheng PP; Liang LM; Wang M; Chen SJ; Huang Y; Song LJ; He XL; Xiong L; Xin JB; Ma WL; Ye H
Biochim Biophys Acta Mol Cell Res; 2020 Nov; 1867(11):118806. PubMed ID: 32739525
[TBL] [Abstract][Full Text] [Related]
7. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Phosphoglycerate Dehydrogenase Attenuates Bleomycin-induced Pulmonary Fibrosis.
Hamanaka RB; Nigdelioglu R; Meliton AY; Tian Y; Witt LJ; O'Leary E; Sun KA; Woods PS; Wu D; Ansbro B; Ard S; Rohde JM; Dulin NO; Guzy RD; Mutlu GM
Am J Respir Cell Mol Biol; 2018 May; 58(5):585-593. PubMed ID: 29019702
[TBL] [Abstract][Full Text] [Related]
10. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
11. VEGF/Src signaling mediated pleural barrier damage and increased permeability contributes to subpleural pulmonary fibrosis.
Lu YZ; Liang LM; Cheng PP; Xiong L; Wang M; Song LJ; Yu F; He XL; Xiong L; Wang XR; Xin JB; Ye H; Ma WL
Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L990-L1004. PubMed ID: 33787325
[TBL] [Abstract][Full Text] [Related]
12. Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis.
Wang D; Gong L; Li Z; Chen H; Xu M; Rong R; Zhang Y; Zhu Q
J Ethnopharmacol; 2021 Dec; 281():114522. PubMed ID: 34391863
[TBL] [Abstract][Full Text] [Related]
13. The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection.
Smoktunowicz N; Alexander RE; Franklin L; Williams AE; Holman B; Mercer PF; Jarai G; Scotton CJ; Chambers RC
Dis Model Mech; 2015 Sep; 8(9):1129-39. PubMed ID: 26138704
[TBL] [Abstract][Full Text] [Related]
14. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models.
Yu W; Guo F; Song X
Pharm Biol; 2017 Dec; 55(1):450-455. PubMed ID: 27937011
[TBL] [Abstract][Full Text] [Related]
15. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
[TBL] [Abstract][Full Text] [Related]
16. AAV6-Mediated IL-10 Expression in the Lung Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Kurosaki F; Uchibori R; Sehara Y; Saga Y; Urabe M; Mizukami H; Hagiwara K; Kume A
Hum Gene Ther; 2018 Nov; 29(11):1242-1251. PubMed ID: 29598007
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles.
Decologne N; Wettstein G; Kolb M; Margetts P; Garrido C; Camus P; Bonniaud P
Eur Respir J; 2010 Jan; 35(1):176-85. PubMed ID: 19574324
[TBL] [Abstract][Full Text] [Related]
18. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR
Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688
[TBL] [Abstract][Full Text] [Related]
20. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.
François A; Gombault A; Villeret B; Alsaleh G; Fanny M; Gasse P; Adam SM; Crestani B; Sibilia J; Schneider P; Bahram S; Quesniaux V; Ryffel B; Wachsmann D; Gottenberg JE; Couillin I
J Autoimmun; 2015 Jan; 56():1-11. PubMed ID: 25441030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]